t6234701 (BioChain Institute)
Structured Review

T6234701, supplied by BioChain Institute, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fda+standard+frozen+tissue+array/pmc08983715-55-11-8
Average 91 stars, based on 1 article reviews
Images
1) Product Images from "RNA aptamers specific for transmembrane p24 trafficking protein 6 and Clusterin for the targeted delivery of imaging reagents and RNA therapeutics to human β cells"
Article Title: RNA aptamers specific for transmembrane p24 trafficking protein 6 and Clusterin for the targeted delivery of imaging reagents and RNA therapeutics to human β cells
Journal: Nature Communications
doi: 10.1038/s41467-022-29377-3
Figure Legend Snippet: List of key resources used in the study.
Techniques Used: Labeling, Expressing, Purification, Microarray, Blocking Assay, Software
Related Articles
Derivative Assay:Article Title: GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab Article Snippet: algorithm , GraphPad Prism 7.0 , GraphPad software , , . .. Other , Expressing:Article Title: GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab Article Snippet: algorithm , GraphPad Prism 7.0 , GraphPad software , , . .. Other , Plasmid Preparation:Article Title: GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab Article Snippet: algorithm , GraphPad Prism 7.0 , GraphPad software , , . .. Other , Transfection:Article Title: GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab Article Snippet: algorithm , GraphPad Prism 7.0 , GraphPad software , , . .. Other , Construct:Article Title: GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab Article Snippet: algorithm , GraphPad Prism 7.0 , GraphPad software , , . .. Other , Activation Assay:Article Title: GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab Article Snippet: algorithm , GraphPad Prism 7.0 , GraphPad software , , . .. Other , In Vivo:Article Title: GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab Article Snippet: algorithm , GraphPad Prism 7.0 , GraphPad software , , . .. Other , Injection:Article Title: GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab Article Snippet: algorithm , GraphPad Prism 7.0 , GraphPad software , , . .. Other , Enzyme-linked Immunosorbent Assay:Article Title: GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab Article Snippet: algorithm , GraphPad Prism 7.0 , GraphPad software , , . .. Other , Sequencing:Article Title: GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab Article Snippet: algorithm , GraphPad Prism 7.0 , GraphPad software , , . .. Other , Recombinant:Article Title: GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab Article Snippet: algorithm , GraphPad Prism 7.0 , GraphPad software , , . .. Other , Software:Article Title: GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab Article Snippet: algorithm , GraphPad Prism 7.0 , GraphPad software , , . .. Other , |
